BAPTIST MEDICAL CTR-NASSAU — History
CCN 100140 | 3-year financial timeline | COVID resilience: 48/100
🛡️ Public data only — no PHI permitted on this instance.
$85M
Latest Revenue (FY2022)
+6.2%
Revenue CAGR (3yr)
2.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $75M | $93M | $85M | -8.8% | +6.2% |
| Operating Expenses | $69M | $79M | $83M | +5.9% | +9.7% |
| Operating Margin | 8.2% | 15.7% | 2.1% | -86.8% | -49.6% |
| Net Income | $6M | $15M | $2M | -87.9% | -46.5% |
| Licensed Beds | 54 | 54 | 54 | +0.0% | +0.0% |
| Total Patient Days | 11,289 | 13,666 | 11,101 | -18.8% | -0.8% |
| Medicare Day % | 44% | 41% | 40% | -3.2% | -4.9% |
| Medicaid Day % | 2% | 2% | 1% | -56.5% | -38.3% |
COVID Impact & Recovery
Resilience Score: 48/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +12.8% ($75M → $85M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.2%
This Hospital
+7.6%
State Avg
Latest Margin
2.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $90M | -1.0% |
| FY2024 (proj) | $95M | -4.0% |
| FY2025 (proj) | $100M | -7.1% |